ConductScience.org, home

Paper21746950

In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin.

Idelevich EA and 8 others. Antimicrob Agents Chemother, 2011. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin. Papers, record 21746950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21746950

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
1.6
iCite
Revised in PubMed
2024-03-20
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Idelevich EAEvgeny A
2von Eiff CChristof
3Friedrich AWAlexander W
4Iannelli DDomenico
5Xia GGuoqing
6Peters GGeorg
7Peschel AAndreas
8Wanninger IIngrid
9Becker KKarsten

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
EndopeptidasesMajor topic
Recombinant ProteinsMajor topic
Staphylococcus aureusMajor topic
Microbial Sensitivity Tests

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116547033Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus.J Bacteriol2006https://conductscience.org/library/papers/16547033PubMed
217955443Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11.J Infect Dis2007https://conductscience.org/library/papers/17955443PubMed
320452280Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.Int J Med Microbiol2010https://conductscience.org/library/papers/20452280PubMed
417085695Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus.Appl Environ Microbiol2007https://conductscience.org/library/papers/17085695PubMed
516445719Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.Clin Microbiol Infect2006https://conductscience.org/library/papers/16445719PubMed
615808314Thermonuclease gene as a target for specific identification of Staphylococcus intermedius isolates: use of a PCR-DNA enzyme immunoassay.Diagn Microbiol Infect Dis2005https://conductscience.org/library/papers/15808314PubMed
711739958Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase.Science2001https://conductscience.org/library/papers/11739958PubMed
820729317Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein.Appl Environ Microbiol2010https://conductscience.org/library/papers/20729317PubMed
916310147The role of nasal carriage in Staphylococcus aureus infections.Lancet Infect Dis2005https://conductscience.org/library/papers/16310147PubMed
1018607587Lysostaphin: an antistaphylococcal agent.Appl Microbiol Biotechnol2008https://conductscience.org/library/papers/18607587PubMed
111406491Bacteriophage lysis: mechanism and regulation.Microbiol Rev1992https://conductscience.org/library/papers/1406491PubMed
125675508Susceptibility of coagulase-negative staphylococci to lysostaphin and other antibiotics.Appl Microbiol1968https://conductscience.org/library/papers/5675508PubMed
1318843708Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers.Cochrane Database Syst Rev2008https://conductscience.org/library/papers/18843708PubMed
1420182526A poke into the diversity and associations within human anterior nare microbial communities.ISME J2010https://conductscience.org/library/papers/20182526PubMed
156639273Chemical composition and structure of cell wall teichoic acids of staphylococci.Arch Microbiol1983https://conductscience.org/library/papers/6639273PubMed
1617997135Staphylococcus aureus of phage type 187 isolated from people occurred to be a genes carrier of eneterotoxin C and toxic shock syndrome toxin-1 (TSST-1).Int J Hyg Environ Health2008https://conductscience.org/library/papers/17997135PubMed
1719673644Mupirocin resistance.Clin Infect Dis2009https://conductscience.org/library/papers/19673644PubMed
1820661301Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice.PLoS One2010https://conductscience.org/library/papers/20661301PubMed
1919913683Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.Diagn Microbiol Infect Dis2009https://conductscience.org/library/papers/19913683PubMed
2019451132Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects.J Antimicrob Chemother2009https://conductscience.org/library/papers/19451132PubMed

See all 35 referencesDownload CSV of references

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
41601319Engineering a Potent Anti-MRSA Agent: The Development and Characterization of Chimeric Endolysin ZAM-MSC.Iran Biomed J2025https://conductscience.org/library/papers/41601319PubMed
41514460Clinical implementation of endolysins targeting gram-positive bacteria points toward a combination strategy with standard-of-care antibiotics: a selective review.Eur J Med Res2026https://conductscience.org/library/papers/41514460PubMed
41463785Recent Advances in Endolysin Engineering.Antibiotics (Basel)2025https://conductscience.org/library/papers/41463785PubMed
40328935[Phage endolysins-a novel class of antibacterial agents with a wide range of applications].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz2025https://conductscience.org/library/papers/40328935PubMed
39549153Phage-Derived Endolysins Against Resistant Staphylococcus spp.: A Review of Features, Antibacterial Activities, and Recent Applications.Infect Dis Ther2025https://conductscience.org/library/papers/39549153PubMed
39508962The Synergistic and Chimeric Mechanism of Bacteriophage Endolysins: Opportunities for Application in Biotherapeutics, Food, and Health Sectors.Probiotics Antimicrob Proteins2025https://conductscience.org/library/papers/39508962PubMed
37101261Therapeutic potential of bacteriophage endolysins for infections caused by Gram-positive bacteria.J Biomed Sci2023https://conductscience.org/library/papers/37101261PubMed
36112205Influence of NaCl and pH on lysostaphin catalytic activity, cell binding, and bacteriolytic activity.Appl Microbiol Biotechnol2022https://conductscience.org/library/papers/36112205PubMed
35208898Exploration of Bacterial Re-Growth as In Vitro Phenomenon Affecting Methods for Analysis of the Antimicrobial Activity of Chimeric Bacteriophage Endolysins.Microorganisms2022https://conductscience.org/library/papers/35208898PubMed
33519773Development of a Novel Chimeric Endolysin, Lys109 With Enhanced Lytic Activity Against Staphylococcus aureus.Front Microbiol2020https://conductscience.org/library/papers/33519773PubMed
32722499Characterization of Clinical MRSA Isolates from Northern Spain and Assessment of Their Susceptibility to Phage-Derived Antimicrobials.Antibiotics (Basel)2020https://conductscience.org/library/papers/32722499PubMed
32042832LytU-SH3b fusion protein as a novel and efficient enzybiotic against methicillin-resistant Staphylococcus aureus.Mol Biol Res Commun2019https://conductscience.org/library/papers/32042832PubMed
30889831Phage Endolysins as Potential Antimicrobials against Multidrug Resistant Vibrio alginolyticus and Vibrio parahaemolyticus: Current Status of Research and Challenges Ahead.Microorganisms2019https://conductscience.org/library/papers/30889831PubMed
30736446In Vitro Activity of the Bacteriophage Endolysin HY-133 against Staphylococcus aureus Small-Colony Variants and Their Corresponding Wild Types.Int J Mol Sci2019https://conductscience.org/library/papers/30736446PubMed
30459750Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials.Front Immunol2018https://conductscience.org/library/papers/30459750PubMed
29735560The Novel Phage-Derived Antimicrobial Agent HY-133 Is Active against Livestock-Associated Methicillin-Resistant Staphylococcus aureus.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29735560PubMed
29734776An Ointment Consisting of the Phage Lysin LysGH15 and Apigenin for Decolonization of Methicillin-Resistant Staphylococcus aureus from Skin Wounds.Viruses2018https://conductscience.org/library/papers/29734776PubMed
295963461st German Phage Symposium-Conference Report.Viruses2018https://conductscience.org/library/papers/29596346PubMed
29362234Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus?mBio2018https://conductscience.org/library/papers/29362234PubMed
29350135Plasmid-Encoded Transferable mecB-Mediated Methicillin Resistance in Staphylococcus aureus.Emerg Infect Dis2018https://conductscience.org/library/papers/29350135PubMed

See all 36 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21746950

GET https://conductscience.org/api/papers/v1/21746950/references?page=2